炎症性肠病表型与病程的性别差异:ENEIDA 注册研究的 SEXEII 研究
这项西班牙多中心观察性研究纳入 51,595 例炎症性肠病患者(52% 为男性,25,947 例为克罗恩病),评估性别与疾病表型及进展的关联。女性克罗恩病中结肠受累、炎症行为及肠外表现风险较高,而上消化道受累、穿透行为、肛周病变及并发症风险较低;溃疡性结肠炎中女性肠外表现风险较高,但 40 岁后发病、左半结肠及广泛结肠受累和腹部手术风险较低。作者认为 IBD 存在性别二态性,临床管理应考虑患者性别。
要点
- 女性是克罗恩病中结肠受累(OR 1.24)、炎症行为(OR 1.14)及肠外表现(OR 1.48)的独立危险因素。
- 女性是克罗恩病上消化道受累(OR 0.84)、穿透行为(OR 0.76)、肛周病变(OR 0.77)及并发症(OR 0.73)的保护因素。
- 溃疡性结肠炎中女性肠外表现风险较高(OR 1.48),但 40 岁后发病、广泛结肠受累及腹部手术风险较低。
核心结论
- 炎症性肠病存在性别二态性,临床管理应考虑患者性别。
研究设计与样本
- 西班牙多中心观察性研究,纳入 ENEIDA 注册中克罗恩病或溃疡性结肠炎患者,数据提取于 2021 年 7 月。
主要发现
- 共纳入 51,595 例 IBD 患者,52% 为男性,25,947 例为克罗恩病;诊断后中位随访男性 9 年、女性 10 年。
- 克罗恩病中女性为中等发病年龄(17-40 岁)的独立危险因素(相对风险比 1.45;95% CI 1.31-1.62),亦为晚发病(>40 岁)的危险因素(相对风险比 1.55;95% CI 1.38-1.73)。
- 克罗恩病中女性与结肠局限受累(OR 1.24;95% CI 1.14-1.34)、炎症行为(OR 1.14;95% CI 1.07-1.21)及肠外表现(OR 1.48;95% CI 1.38-1.59)风险升高相关。
- 克罗恩病中女性与上消化道受累(OR 0.84;95% CI 0.79-0.90)、穿透行为(OR 0.76;95% CI 0.70-0.82)、肛周病变(OR 0.77;95% CI 0.71-0.82)及并发症(OR 0.73;95% CI 0.66-0.80)风险降低相关。
- 溃疡性结肠炎中女性为肠外表现的独立危险因素(OR 1.48;95% CI 1.26-1.61),但与 40 岁后发病(相对风险比 0.76;95% CI 0.66-0.87)、左半结肠受累(相对风险比 0.72;95% CI 0.67-0.78)、广泛结肠受累(相对风险比 0.59;95% CI 0.55-0.64)及腹部手术(OR 0.78;95% CI 0.69-0.88)风险降低相关。
临床怎么用
- 作者认为临床管理炎症性肠病时应考虑患者性别。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: The impact of patient sex on the presentation of inflammatory bowel disease (IBD) has been poorly evaluated. Our aims were to assess potential disparities in IBD phenotype and progression between sexes. METHODS: We performed an observational multicenter study that included patients with Crohn's disease (CD) or ulcerative colitis from the Spanish Estudio Nacional en Enfermedad Inflamatoria intestinal sobre Determinantes genéticos y Ambientales registry. Data extraction was conducted in July 2021. RESULTS: A total of 51,595 patients with IBD were included, 52% were males and 25,947 had CD. The median follow-up period after diagnosis was 9 years in males and 10 years in females. In CD, female sex was an independent risk factor for medium disease onset (age, 17-40 y) (relative risk ratio, 1.45; 95% CI, 1.31-1.62), later disease onset (age, >40 y) (relative risk ratio, 1.55; 95% CI, 1.38-1.73), exclusive colonic involvement (odds ratio, 1.24; 95% CI, 1.14-1.34), inflammatory behavior (odds ratio, 1.14; 95% CI, 1.07-1.21), and extraintestinal manifestations (odds ratio, 1.48; 95% CI, 1.38-1.59). However, female sex was a protective factor for upper gastrointestinal involvement (odds ratio, 0.84; 95% CI, 0.79-0.90), penetrating behavior (odds ratio, 0.76; 95% CI, 0.70-0.82), perianal disease (odds ratio, 0.77; 95% CI, 0.71-0.82), and complications (odds ratio, 0.73; 95% CI, 0.66-0.80). In ulcerative colitis, female sex was an independent risk factor for extraintestinal manifestations (odds ratio, 1.48; 95% CI, 1.26-1.61). However, female sex was an independent protective factor for disease onset from age 40 onward (relative risk ratio, 0.76; 95% CI, 0.66-0.87), left-sided colonic involvement (relative risk ratio, 0.72; 95% CI, 0.67-0.78), extensive colonic involvement (relative risk ratio, 0.59; 95% CI, 0.55-0.64), and abdominal surgery (odds ratio, 0.78; 95% CI, 0.69-0.88). CONCLUSIONS: There is sexual dimorphism in IBD. The patient's sex should be taken into account in the clinical management of the disease.
引用
- Gargallo-Puyuelo CJ, Ricart E, Iglesias E, et al. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA. Clin Gastroenterol Hepatol. 2024. PMID: 38782172. doi:10.1016/j.cgh.2024.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。